Pharmacyte Biotech Stock Price on September 27, 2024

PMCB Stock  USD 1.62  0.05  2.99%   
Below is the normalized historical share price chart for PharmaCyte Biotech extending back to September 11, 2003. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of PharmaCyte Biotech stands at 1.62, as last reported on the 11th of December 2024, with the highest price reaching 1.70 and the lowest price hitting 1.60 during the day.
IPO Date
17th of September 2010
200 Day MA
1.9648
50 Day MA
1.7632
Beta
(0.20)
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in PharmaCyte Stock, it is important to understand the factors that can impact its price. PharmaCyte Biotech maintains Sharpe Ratio (i.e., Efficiency) of -0.0108, which implies the firm had a -0.0108% return per unit of risk over the last 3 months. PharmaCyte Biotech exposes twenty-eight different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check PharmaCyte Biotech's Semi Deviation of 4.67, risk adjusted performance of 0.038, and Coefficient Of Variation of 2457.68 to confirm the risk estimate we provide.
  
At present, PharmaCyte Biotech's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 150.5 M, whereas Common Stock Total Equity is forecasted to decline to 173.71. . At present, PharmaCyte Biotech's Price To Sales Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Earnings Ratio is expected to grow to 63.90, whereas Price To Operating Cash Flows Ratio is forecasted to decline to (9.91). PharmaCyte Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0108

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsPMCB

Estimated Market Risk

 4.92
  actual daily
43
57% of assets are more volatile

Expected Return

 -0.05
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.01
  actual daily
0
Most of other assets perform better
Based on monthly moving average PharmaCyte Biotech is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of PharmaCyte Biotech by adding PharmaCyte Biotech to a well-diversified portfolio.
Price Book
0.264
Book Value
6.182
Enterprise Value
-14.7 M
Enterprise Value Ebitda
(12.02)
Shares Float
7.3 M

Related Headline

Y MAbs Headline on 27th of September 2024

Insider Trading
by Tagliaferri Mary
Filed transaction by Y mAbs Therapeutics Director . Insider Public Trading

PharmaCyte Biotech Valuation on September 27, 2024

It is possible to determine the worth of PharmaCyte Biotech on a given historical date. On September 27, 2024 PharmaCyte was worth 1.78 at the beginning of the trading date compared to the closed value of 1.84. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of PharmaCyte Biotech stock. Still, in general, we apply an absolute valuation method to find PharmaCyte Biotech's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of PharmaCyte Biotech where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against PharmaCyte Biotech's related companies.
 Open High Low Close Volume
  1.70    1.94    1.70    1.80    20,063  
09/27/2024
  1.78    1.95    1.78    1.84    18,277  
  1.88    2.06    1.80    1.91    43,721  
Backtest PharmaCyte Biotech  |  PharmaCyte Biotech History  |  PharmaCyte Biotech Valuation   PreviousNext  
Open Value
1.78
1.84
Closing Value
16.54
Upside

PharmaCyte Biotech Trading Date Momentum on September 27, 2024

On September 30 2024 PharmaCyte Biotech was traded for  1.91  at the closing time. The top price for the day was 2.06  and the lowest listed price was  1.80 . The trading volume for the day was 43.7 K. The trading history from September 30, 2024 was a factor to the next trading day price jump. The trading delta at closing time against the next closing price was 3.80% . The trading delta at closing time against the current closing price is 3.80% .

PharmaCyte Biotech Fundamentals Correlations and Trends

By evaluating PharmaCyte Biotech's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among PharmaCyte Biotech's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. PharmaCyte financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About PharmaCyte Biotech Stock history

PharmaCyte Biotech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for PharmaCyte is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in PharmaCyte Biotech will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing PharmaCyte Biotech stock prices may prove useful in developing a viable investing in PharmaCyte Biotech
Last ReportedProjected for Next Year
Common Stock Shares Outstanding9.6 M9.1 M
Net Loss-4.9 M-5.1 M

PharmaCyte Biotech Stock Technical Analysis

PharmaCyte Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of PharmaCyte Biotech technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of PharmaCyte Biotech trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

PharmaCyte Biotech Period Price Range

Low
December 11, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

PharmaCyte Biotech cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

PharmaCyte Biotech December 11, 2024 Market Strength

Market strength indicators help investors to evaluate how PharmaCyte Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading PharmaCyte Biotech shares will generate the highest return on investment. By undertsting and applying PharmaCyte Biotech stock market strength indicators, traders can identify PharmaCyte Biotech entry and exit signals to maximize returns

PharmaCyte Biotech Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for PharmaCyte Biotech's price direction in advance. Along with the technical and fundamental analysis of PharmaCyte Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of PharmaCyte to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for PharmaCyte Stock analysis

When running PharmaCyte Biotech's price analysis, check to measure PharmaCyte Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PharmaCyte Biotech is operating at the current time. Most of PharmaCyte Biotech's value examination focuses on studying past and present price action to predict the probability of PharmaCyte Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PharmaCyte Biotech's price. Additionally, you may evaluate how the addition of PharmaCyte Biotech to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Fundamental Analysis
View fundamental data based on most recent published financial statements
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios